Notice of Intent to Sole Source - BioSearch Technologies INC.

The Contractor is obligated to manufacture, assemble, perform quality control, package, and deliver real-time polymerase chain reaction (PCR) primer and probe kits according to government-approved technical and manufacturing specifications, applicable regulatory standards, and individual delivery orders under the Blanket Purchase Agreement. The kits must be commercially produced, dried or lyophilized, and fully compliant with FDA Quality System Regulations (21 CFR 820), using Black Hole Quencher (BHQ) probe chemistry to ensure compatibility with existing validated assays. The Contractor is responsible for the full end-to-end production lifecycle, including synthesis of primers and probes, pilot and full-scale manufacturing, quality assurance, kit assembly, labeling, packaging, and final delivery, all performed at the Contractor’s facilities unless otherwise approved. All technical, quality control, security, and assembly requirements are detailed in individual task orders issued under the agreement and are binding when invoked. The Contractor must securely handle sensitive primer and probe sequences and adhere strictly to the specifications outlined in each task order. The procurement is being conducted as a sole source action under the CDC Office of Acquisition Services, with the place of performance located in Atlanta, Georgia. The contract vehicle is linked to NAICS code 325199 and is managed by the Department of Health and Human Services, with point of contact Marcus Lindsey available for inquiries via email and phone. The notice of intent was posted on July 8, 2026, with responses due by July 23, 2026.